The Ikarian Mountain Honey + Lithium Trick That Survived 50 Years of Pharma Marketing.

Short answer: Almost always normal age-related retrieval slowdown, not Alzheimer's disease.

After 50, "tip-of-the-tongue" moments become more common — you know the word, you just can't retrieve it as fast. This is a retrieval problem, not a storage problem, and it's a normal part of healthy aging.

True Alzheimer's involves persistent memory loss that disrupts daily life: forgetting recently-learned information, getting lost in familiar places, confusion with time or place. If you're experiencing those patterns, please see a neurologist. MemoPryl is a dietary supplement designed to support natural memory recall in healthy adults — it does not diagnose, treat, cure, or prevent any disease.

Different molecule, different dose, different regulatory category.

Prescription lithium (lithium carbonate or lithium citrate) is dosed at 300–1,800 mg/day for mood disorders. It has a narrow therapeutic window and requires regular blood-level monitoring because the dose is close to the toxicity threshold.

Lithium orotate, the form in MemoPryl, is dosed at 5 mg/day — about 100× smaller. It is classified as a dietary supplement by the FDA (not a prescription drug), and is sold over the counter. The orotate carrier is thought to help the lithium cross cell membranes more efficiently at low doses.

Both compounds contain lithium, but they are not interchangeable. Do not stop prescription lithium and start MemoPryl — that is a decision for your prescribing doctor.

Yes — the microdose is the whole point.

The 2025 Nature paper on lithium and memory described effects at doses 100× smaller than what pharmaceutical companies ever tested. The reason pharmaceutical companies never patented low-dose lithium is that you can't patent a dose of a naturally occurring mineral — there's no financial incentive.

A useful analogy: folate vs folic acid. Same compound, different dose, different use. The microdose works at the cellular level (mitochondrial function, BDNF support) without producing the blood-level spikes associated with prescription lithium.

We're not saying 5 mg is a magic number. We're saying the research summary supports it, and 90 days is enough time to notice a difference — or your money back.

MemoPryl is a dietary supplement with 3 ingredients at low doses. Generally well-tolerated by healthy adults.

However, always consult a qualified healthcare professional before starting any new supplement if you:

• Take prescription lithium, mood stabilizers, or thyroid medication
• Take blood pressure medication (MemoPryl is not a substitute)
• Are pregnant, nursing, or planning pregnancy
• Have a pre-existing medical condition, especially kidney or thyroid
• Are scheduled for surgery (stop 2 weeks before)

Print the ingredients panel above and bring it to your doctor. We make this easy because we want you to be safe, not because we expect a problem.

Most users report noticing "smoother recall" around day 14–30. Full effect compounds over 60–90 days.

The 3-compound order (Trigger. Protect. Activate.) is designed to work in sequence, not all at once:

• Days 1–14: First-pass absorption, no noticeable effect yet (this is normal)
• Days 14–30: Smoother word recall, less "tip-of-the-tongue" moments
• Days 30–60: More consistent recall across the day, less afternoon fog
• Days 60–90: Sustained support; this is the period most users evaluate the product on

Memory support is not an instant "switch" — it's a compounding process. The 90-day timeline is intentional.

90-day money-back guarantee, empty bottles accepted.

If after 90 days of consistent daily use you don't notice a difference, here's what to do:

1. Email support@memopryl.com with your order number
2. We'll send a prepaid return label
3. Box up the bottles (empty or full — we don't judge)
4. Drop it off at any UPS store
5. Refund posts to your original payment method within 5 business days of receipt

No restocking fee. No "we'll send you a discount to try again." No questions beyond the order number. We stand behind the 90-day timeline because the science supports it.

Regulatory classification depends on dose and intended use, not just the molecule.

The FDA classifies substances as drugs when they are "intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease" or when their dose is "recognized by experts as requiring medical supervision."

Lithium orotate at 5 mg falls below the threshold where medical supervision is required, and is sold as a dietary supplement for general wellness and memory support. MemoPryl makes no drug claims — we use structure-function language ("may support memory and recall") because that's what the regulatory framework permits at this dose.

If a product claims lithium orotate "treats" or "prevents" Alzheimer's, that's a red flag — they're making drug claims without FDA approval. MemoPryl doesn't do that.